ISSN: 7027-2221

Keywords : Childhood asthma

Erectile Dysfunction in Diabetic Patients in the Holy Kerbala/Iraq in 2018

karbala journal of pharmaceutical sciences, 2018, Volume 9, Issue 15, Pages 1-10

Erectile dysfunction affects more than 50% of diabetic patients and results in miserable
couple’s life, especially for young adults. Possible predictors are proper therapy and
patient’s compliance with treatment, in addition to the warning signs and symptoms of
sensory neuron and motor deficits. Therefore, this study was conducted to determine the
prevalence of Erectile dysfunction and its predictors among diabetic patients in Kerbala.
Material and methods
The study included a convenient sample of 61 patients with diabetes mellitus type I and II.
They were chosen through a systematic sampling among patients at the diabetes mellitus
clinic at Al Hussein Teaching Hospital in Holy Kerbala /Iraq in 2018. All participants
were interviewed using standard questionnaire. Analysis of data used descriptive and
analytic tools including t-test, chi-square test, logistic regression and structural Equation
modeling through the statistical Package of social sciences and Amos and Excel software
at a significance level of


diabetes mellitus
erectile dysfunction
Autonomic changes
sensory and motor changes
glycemic control.

A Comparative Study of Salbutamol Nebulizer versus Ipratropium Bromide plus Salbutamol Nebulizer in the Treatment of Children with Acute Asthma Exacerbation

karbala journal of pharmaceutical sciences, 2018, Volume 9, Issue 15, Pages 122-137

Background: Patients with asthma may develop acute attack due to different types
of triggering factors. Early recognition of an acute asthma exacerbation is crucial
for effective management.
Objectives: To evaluate the effects of salbutamol nebulizer versus salbutamol plus
ipratropium bromide nebulizer in children with acute asthma exacerbation attack.
Patients and methods: A randomized double blind standard control clinical study
was conducted in Karbala Teaching Hospital for Children from 1st of November
2015 to the end of November 2016 on patients presented to the emergency room
(ER) of the Hospital. The study was conducted on hundred patients presented with
mild to moderate acute attacks of asthma, assigned to take either nebulized
salbutamol or combination of salbutamol plus ipratropium bromide during their
stay. Assessment of asthma severity was done for each patient according to
pulmonary index score (PIS)
Results: There was significant reduction (p <0.05) in PIS for patients treated with
salbutamol alone and patients treated with combination therapy (ipratropium +
salbutamol) after 30,60 and 90 minutes from ER admission as compare with their
scores at baseline, 30 and 60 minutes respectively. After 30 minutes from ER
admission, patients who were treated with combination of ipratropium bromide +
salbutamol had significantly (p <0.05) lower PIS (5.60±2.77) than those treated
with salbutamol alone (PIS=7.32±2.18). The mean duration of stay in ER was significantly (p <0.05) shorter in patient treated with combination therapy
(57.60±21.71 min) than those with salbutamol alone (77.40±16.13 min).
Conclusion: Treatment of asthmatic children with mild to moderate acute
exacerbation attack with combination therapy of (ipratropium plus salbutamol
nebulizer) improved the clinical condition, lowered pulmonary index score, and
significantly shortened the duration of stay in emergency room as compared with
salbutamol nebulizer alone..

Total Serum IgE Level in Relation to Some Risk Factors of Childhood Asthma

Haidar A. N. Abood; Mohammad R. I. Ghazal; Zuhair M. Al-Musawi

karbala journal of pharmaceutical sciences, 2013, Volume 4, Issue 6, Pages 78-84

Measurement of total serum IgE (TSIgE) levels in asthmatic children can be used for supporting the diagnosis of allergic asthma, predicting asthma severity and monitoring response to therapy. Elevated TSIgE level is important risk factor for persistent childhood asthma. The present study aims to determine the extent of elevation in TSIgE levels among asthmatic children and its association with some risk factors of childhood asthma. This cross sectional study was conducted in Kerbala Teaching Hospital for Children on 154 asthmatic children. An interview was conducted with patients (including their parents) through a questionnaire prepared for this purpose to report patient's information and clinical data. All patients were screened for the presence of elevated TSIgE by a qualitative method followed by quantitative measurement of TSIgE concentration. Absolute eosinophils count was also determined. Seventy five (48.7%) patients showed positive IgE screening test and 79 (51.3%) patients showed negative IgE screening test. 61.4% of asthmatic children in the age group 5-10 years and 55.5% of patients in the age group >10 years were IgE (+ve), while only 33.3% of patients in the age group <5 years were IgE (+ve). The mean TSIgE level was 874.97±1323.85 IU/ml for IgE (+ve) patients (56% had levels <500, 21.3% between 500-1000, and 22.7% >1000 IU/ml) and 38.19±19.23 IU/ml for IgE (-ve) patients. The ages of patients in the IgE (+ve) group were significantly higher (P<0.01) than those for patients in the IgE (-ve) group. No significant differences (P>0.05) were observed between patients in both groups regarding absolute eosinophils count, patient's weight, gender, positive personal history of atopic dermatitis and/or allergic rhinitis, positive family history of asthma and exposure to smoking . In conclusion, there is high association between age and TSIgE levels in asthmatic children, with elevated levels mostly seen in older children. No association present between elevation in TSIgE and other risk factors for childhood asthma like; male gender, positive family history of asthma, exposure to tobacco smoke and peripheral blood eosinophilia.